Estrov Z - Search Results

1

Achieving complete remission in CLL patients treated with ibrutinib: clinical significance and predictive factors.

Strati P, Schlette EJ, Solis Soto LM, Duenas DE, Sivina M, Kim E, Keating MJ, Wierda WG, Ferrajoli A, Kantarjian H, Estrov Z, Jain N, Thompson PA, Wistuba II, Burger JA. Strati P, et al. Among authors: estrov z. Blood. 2020 Feb 13;135(7):510-513. doi: 10.1182/blood.2019003570. Blood. 2020. PMID: 31895947 Free PMC article. Clinical Trial. No abstract available.

2

Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.

Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Gutterman JU, Talpaz M. Estrov Z, et al. Blood. 1992 Apr 15;79(8):1938-45. Blood. 1992. PMID: 1373331 Free article.

3

Differentiation in B-precursor acute lymphoblastic leukemia cell populations with CD34-positive subpopulations.

Re GG, Estrov Z, Antoun GR, Felix EA, Pinkel DP, Zipf TF. Re GG, et al. Among authors: estrov z. Blood. 1991 Aug 1;78(3):575-80. Blood. 1991. PMID: 1713508 Free article.

4

Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity.

Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M. Estrov Z, et al. Blood. 1991 Sep 15;78(6):1476-84. Blood. 1991. PMID: 1715791 Free article.

5

Growth factors controlling interleukin-4 action on hematopoietic progenitors.

Ferrajoli A, Zipf TF, Talpaz M, Felix EA, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Ann Hematol. 1993 Dec;67(6):277-84. doi: 10.1007/BF01696347. Ann Hematol. 1993. PMID: 7506581

6

Interleukin 4 alters human bone marrow stroma and modulates its interaction with hematopoietic progenitors.

Ferrajoli A, Talpaz M, Ordonez NG, Stanley ER, Hirsch-Ginsberg C, Zipf TF, Wetzler M, Kurzrock R, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Stem Cells. 1994 Nov;12(6):638-49. doi: 10.1002/stem.5530120611. Stem Cells. 1994. PMID: 7533582

7

Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.

Drach D, Estrov Z, Zhao S, Drach J, Cork A, Collins D, Kantarjian H, Andreeff M. Drach D, et al. Among authors: estrov z. Leuk Lymphoma. 1994 Dec;16(1-2):79-88. doi: 10.3109/10428199409114143. Leuk Lymphoma. 1994. PMID: 7535143

8

Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies.

Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R. Talpaz M, et al. Among authors: estrov z. J Clin Invest. 1994 Oct;94(4):1383-9. doi: 10.1172/JCI117473. J Clin Invest. 1994. PMID: 7929813 Free PMC article.

9

Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates.

Wetzler M, Kurzrock R, Estrov Z, Kantarjian H, Gisslinger H, Underbrink MP, Talpaz M. Wetzler M, et al. Among authors: estrov z. Blood. 1994 Nov 1;84(9):3142-7. Blood. 1994. PMID: 7949186 Free article. Clinical Trial.

10

Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.

Ferrajoli A, Talpaz M, Zipf TF, Hirsch-Ginsberg C, Estey E, Wolpe SD, Estrov Z. Ferrajoli A, et al. Among authors: estrov z. Leukemia. 1994 May;8(5):798-805. Leukemia. 1994. PMID: 8182937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters